For supplement and nutraceutical brands, there’s no better time to seize the booming joint health market opportunity. Download Lonza’s NEW eBook to discover what consumers want, and how to capture market share and consumer attention in the dynamic joint health category with UC-II® undenatured type II collagen.
This Technical Paper is from Lonza.
![](https://assets.innovamarketinsights360.com/insights/Common/Images/up.png)
Muenchensteinerstrasse 38
Basel
4002
Switzerland
HEALTH CATEGORIES
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.
Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.
![](https://assets.innovamarketinsights360.com/insights/Common/Images/up.png)
NUTRITION & HEALTH NEWS
Ancient Chinese medicinal fungus could combat pulmonary fibrosis, research suggests
26 Jul 2024 --- Cordyceps sinensis, a fungus used in Traditional Chinese Medicinal (TCM), is shown to ameliorate the severe respiratory disease idiopathic pulmonary fibrosis (IPF) in mice. The natural medicine inhibits... Read More
NUTRITION & HEALTH NEWS
Navigating the South African Biotrade and Bioprospecting system with Parceval
26 Jul 2024 --- Although South Africa has established a rigid and cumbersome legal system governing access to indigenous biodiversity and associated traditional knowledge, Parceval has secured several permits. The South... Read More
NUTRITION & HEALTH NEWS
Sabinsa’s beetroot extract sprouts success in safety study of older population
26 Jul 2024 --- Nutraceutical specialist Sabinsa conducted a preliminary study analyzing the safety, tolerability and health benefits of daily supplementation of its Sabeet beetroot extract in older adults and found it well... Read More
BUSINESS NEWS
26 Jul 2024 --- This week in nutrition news, Cheribundi revealed five Team USA Olympic athletes will represent the company at the Paris games, Brightseed and Manitoba Harvest unveiled two new flavors for their Bioactive Fiber... Read More
NUTRITION & HEALTH NEWS
New joint report on state of world food security reveals worrying decline in nutrition
25 Jul 2024 --- The annual State of Food Security and Nutrition in the World by the UN’s Food and Agriculture Organization (FAO), the International Fund for Agricultural Development (IFAD), the United Nations... Read More
![](https://assets.innovamarketinsights360.com/insights/Common/Images/up.png)
IFT First 2024 live: Balchem launches cold-water soluble oat creamer for cognition
17 Jul 2024 --- At the ongoing IFT First trade show in Chicago, US, we catch up with Josephine Nakhla, director of strategic marketing and business development for powders and cereals at Balchem. Nakhla discusses the applications and benefits of the VitalBlend Oat 2540 cold-water soluble oat creamer the company launches at the event. She further gives her insights into the company’s wellness-oriented VitalBlend among other recently-launched and upcoming Balchem products.
Daesang: Pioneering plant-based nutrition with GoldRella and White Chlorella
11 Jul 2024 --- At Daesang’s headquarters in Seoul, Korea, we sit down with Angie Jang, the company’s marketing manager for the marketing division of the ingredient business unit, to discuss the multifunctional benefits and versatility of its GoldRella and White Chlorella solutions for plant-based food applications. Jang also details the company’s future vision for these innovative offerings.
InGood by Olga: Circular approach blooms with signature upcycled yellow pea
27 Jun 2024 --- InGood by Olga’s upcycled yellow pea ingredient Peakara has been designed for active and senior nutrition formulations. We caught up with Charlotte Bastian, business unit manager, who describes the concentrate as having a complex amino acid profile featuring unsaturated fatty acids and fibers with a chemical index of 157 and digestibility of PDCAAS of 1. The company also outlined its Vision 2035 circular business strategy.
Euromed: Clinical evidence is crucial to sustain innovative claims
25 Jun 2024 --- Andrea Zangara, the head of scientific communication and medical affairs at Euromed, highlights how cutting-edge science, tradition and commitment to sustainability drive innovation at the company. He details new clinical research on Euromed’s cucumber and spinach extracts, which both support healthy aging — improving joint and muscle health. In the future, Euromed will expand its Mediterranean portfolio, prioritizing weight management, sleep and cognitive function.
Hi & Fi Asia-China 2024 live: Personalized nutraceuticals drive biotics space in China
21 Jun 2024 --- Novonesis is continuing to grow its probiotics business in China alongside its HMO prebiotics. The expanding “biotics” space is being driven by a desire for more personalized nutrition solutions, says Jakob Dalmose Rasmussen, VP of Human Health Biosolutions at Novonesis. He shares insights into the Chinese market and introduces a product being launched exclusively in the country — SmartGuard for kids.
![](https://assets.innovamarketinsights360.com/insights/Common/Images/up.png)
Innovation in Folate Nutrition: How Optifolin+™ Supports Prenatal, Brain, and Heart Health
18 Jul 2024 --- Discover Balchem’s new patented choline-enriched L-5-MTHF ingredient, Optifolin+™ and how this innovative folate form supports optimal cellular health across all life stages. From prenatal through adulthood explore how this scientific breakthrough opens transformative potential in dietary supplementation.
Postbiotics in Focus: A New Approach to Holistic Health
19 Jun 2024 --- Deep dive into the world of biotics and the microbiome. This webinar brought to you by KHNI looks to explore the science behind postbiotics, along with the potential role postbiotics can play as a vehicle to meet consumer needs in not only digestive health, but beyond this to other areas of consumer interest, such as immune and cognitive health. The increased focus on postbiotics has been spurred on by the explosion of research and patent filings in this area. In addition to this, increased desire to age both gracefully and healthily, along with growing awareness of the links between systems throughout the body has created a focus on the impact one health system may have on another.
The Editor Presents: Satisfying Soups & Sauces
14 Jun 2024 --- Join The World of Food Ingredients’ editor, Missy Green, in a 15-minute roundup of highlights from the soups and sauces edition.Inspiration from global cuisines is becoming more nuanced with African flavors coming into the spotlight. Authentic spice blends true to regional tastes are elevating foods, while limited editions allow consumers to dip into novel experiences.This edition also explores today’s bakery trends and Brazil’s booming ingredients sector. In health and wellness, we examine the latest biotic ingredients and healthy aging ingredients for active seniors.
The psychobiotic era: A fast-growing mental wellness market
28 May 2024 --- Today's consumer choice is shifting! People are currently on a hunt for scientifically proven, safe, effective and high-quality solutions to address the multifaceted and interconnected dimensions of mental wellness.Join this webinar "the psychobiotic era: A fast-growing mental wellness market" to hear from our panel of experts who will deep dive into some very interesting market data and consumer insights in the world of mental wellness, before sharing more scientific information about our unique psychobiotic solution containing Bifidobacterium Longum 1714™ strain: ProbioBrain™.
Meet the compliance challenges for Supplements in Europe and in the US thanks to R&D Insight
21 May 2024 --- There are so many regulatory sources to check if an ingredient is authorized for nutritional purpose in the European Union with national specificities. The regulatory frameworks governing ingredients for nutritional use in food and dietary supplements as well as Health Claims, differ between the European Union and the U.S.Our digital solution Supplements R&D Insight summarizes the European and American regulatory status of ingredients (authorized, restricted or forbidden). In addition to a great source for product ideation, the scientific part enables to determine whether sufficient data exist to support your pending Health Claims in Europe and structure/function claims in the U.S.